• ERADECs Hijack ERAD to Degrade Transmembrane Proteins

  2026-08-20

  Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that recruits the ER E3 ligase SYVN1 to eliminate transmembrane proteins. PD-L1-directed ERADECs achieved sub-nanomolar activity and strong tumor suppression, illustrating how ER-associated degradation can address limitations of proteasome- and lysosome-centered approaches.

• Penicillin G Sodium: From Mechanism to Translation

  2026-08-20

  A translational perspective on Penicillin G Sodium that connects bacterial cell wall biology, exposure design, resistance-aware validation, and clinically relevant research strategy.

• BMS-777607: c-Met Inhibitor Evidence & Workflow

  2026-08-19

  BMS-777607 is an orally available, ATP-competitive c-Met inhibitor with reported activity against c-Met, Axl, Ron, and Tyro3. Its strongest dossier-supported use is pathway perturbation in cancer metastasis models, while its role in hiPSC-derived platelet workflows remains investigational.

• AG-120: Metabolic Logic of IDH1 Inhibition

  2026-08-19

  AG-120 (Ivosidenib) is a selective mutant IDH1 inhibitor whose value extends beyond 2-hydroxyglutarate reduction. This article explains how metabolic rewiring, CD44 biology, and differentiation assays can be integrated to interpret AML mutant IDH1 treatment experiments more rigorously.

• Palonosetron Hydrochloride: Precision in Translation

  2026-08-18

  A translational perspective on palonosetron hydrochloride that connects 5-HT3 receptor pharmacology, renal transporter assays, antiemetic strategy, and experimental design for cancer research.

• Recombinant Human Oncostatin M: Assay Workflows

  2026-08-18

  Build reproducible proliferation, cytokine-release, and inflammatory co-treatment assays with a tag-free, lyophilized OSM reagent. This guide translates product specifications and recent cancer-cell-death findings into practical workflows, controls, and troubleshooting decisions.

• Recombinant Mouse SHH: An Assay-Design Guide

  2026-08-17

  Recombinant Mouse Sonic Hedgehog is more than a pathway reagent: it is a controllable perturbation for testing developmental patterning hypotheses. This guide connects SHH protein specifications with comparative genital development research, assay design, and interpretation.

• Thioredoxin Control of CHK1 Inhibitor Sensitivity

  2026-08-16

  This 2024 Nature Communications study identifies thioredoxin 1 as a determinant of CHK1 inhibitor response in non-small cell lung cancer. Its central innovation is the mechanistic connection between thioredoxin-dependent redox recycling of RRM1, ribonucleotide reductase activity, deoxynucleotide availability, and replication-stress survival, revealing a rationale for combining CHK1 and thioredoxin reductase inhibitors.

• Proteoform-Specific Drug Targeting in Native Membranes

  2026-08-15

  Lutomski and colleagues developed a native top-down mass spectrometry strategy that releases membrane proteins and signaling complexes directly from retinal disc membranes, preserving information about proteoforms, lipid modifications, and ligand interactions. The study shows how this approach can distinguish drug binding to modified protein states, providing a more precise framework for interpreting off-target interactions than conventional ensemble assays.

• Tetramethylrhodamine Ethyl Ester Perchlorate for ΔΨm

  2026-08-15

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) converts mitochondrial membrane potential into a live-cell fluorescence readout for microscopy and flow cytometry. This guide shows how to use SKU C8197 to distinguish depolarization from ROS-driven injury, including trichothecene toxicity workflows and practical troubleshooting.

• Hematoxylin and Eosin Staining Kit: Lab Guide

  2026-08-14

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for tissue morphology visualization in paraffin-embedded sections, frozen sections, and cytological preparations. It supports research-focused histopathological and cytological staining, but it is not intended for diagnostic or medical use.

• Lisinopril Dihydrate: From ACE Inhibition to Translation

  2026-08-14

  Lisinopril dihydrate is more than a familiar antihypertensive tool: it is a controlled perturbation of renin–angiotensin signaling. This thought-leadership analysis connects ACE biology, aminopeptidase selectivity, formulation discipline, and model-specific validation to help translational researchers design more interpretable hypertension, heart failure, acute myocardial infarction, and diabetic nephropathy studies.

• Hematoxylin and Eosin Staining for Ferroptosis Studies

  2026-08-13

  Learn how an H&E staining kit can connect tissue morphology with ferroptosis research in acute lung injury. This guide explains staining chemistry, assay interpretation, workflow controls, and the mechanistic insight provided by recent Keap1–Nrf2–GPX4 research.

• Dimetridazole Workflows for Antimicrobial Research

  2026-08-13

  Build a layered Dimetridazole workflow that separates growth inhibition from quorum-sensing and biofilm effects, then verifies compound identity with sensitive electrochemical detection. Practical controls, concentration planning, and troubleshooting guidance help connect bacterial culture assays with infection model research.

• GnRH Antagonists with 2-OMe-5Pal at Position 3

  2026-08-12

  Samant and colleagues synthesized two degarelix analogs containing racemic 3-(2-methoxy-5-pyridyl)-alanine at position 3, separated the resulting diastereomers, and assigned their stereochemistry enzymatically. The D-configured analog retained strong in vitro antagonism of the human GnRH receptor, whereas the L-configured analog was weaker and both compounds were short-acting in the rat assay, highlighting the importance of stereochemistry and scaffold-specific pharmacology.

462 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page